Tim Clover, CEO of t+ Medical Holdings, and Andrew Hall, founder and managing director of Vivatec, in a joint statement said: “This acquisition enables t+ Medical to expand its current offering by adding an extensive range of medical device technologies to its remote patient monitoring solutions and ePRO technologies for clinical trials.
“The synergy between the two companies provides an ideal base from which to further deliver the benefits of mobile telephones in healthcare and we expect that this latest development will enable the rapid growth that we have experienced to continue.”